Umami Bioworks is expanding its cultivated marine cell platform to produce polydeoxyribonucleotide (PDRN) from a wider range of aquatic species, including eel, tuna, and sturgeon. This development aims to provide an alternative to extracting PDRN from salmon milt, addressing ethical and environmental concerns associated with traditional extraction methods. By using a cultivated cell platform, the company is working to broaden access to marine DNA materials without relying on wild-caught sources.

Comparative studies are being conducted to evaluate the biological activity of PDRN derived from different marine species against the industry standard sourced from salmon. Early data suggest variations in performance across species, with potential applications in differentiated skincare formulations. Umami Bioworks is currently in discussions with cosmetic manufacturers and formulation companies to commercialize the cultivated marine PDRN for use in high-performance skincare products that rely on regenerative actives.